Table 1.
Participants' Characteristics at Baseline and According to Diabetes Status at Follow-Up
| Total (n=2638) | Diabetes (n=162) | No Diabetes (n=2476) | |
|---|---|---|---|
| Age, y | 59±9 | 62±9 | 59±9 |
| Women, % | 1479 (56) | 69 (43) | 1410 (57) |
| Race, n (%) | |||
| White | 2449 (93) | 144 (89) | 2305 (93) |
| African American | 81 (3) | 7 (4) | 74 (3) |
| Hispanic | 51 (2) | 5 (3) | 46 (2) |
| Asian | 57 (2) | 6 (4) | 51 (2) |
| Omni, n (%) | 189 (7) | 18 (11) | 171 (7) |
| Body mass index, kg/m2 | 27.7±5.1 | 31.5±5.6 | 27.5±4.9 |
| Glucose, mg/dL | 97±10 | 109±11 | 96±9 |
| Triglycerides, mg/dL | 129±80 | 180±136 | 125±73 |
| High-density lipoprotein cholesterol, mg/dL | 55±17 | 46±14 | 56±17 |
| Systolic blood pressure, mm Hg | 125±18 | 135±18 | 124±18 |
| Impaired fasting glucose, n (%) | 890 (34) | 121 (75) | 769 (31) |
| Hypertension, n (%) | 1018 (39) | 110 (68) | 908 (37) |
| Hypertension treatment, n (%) | 712 (27) | 78 (48) | 634 (26) |
| Lipid treatment, n (%) | 444 (17) | 48 (30) | 396 (16) |
| Smoking, n (%) | 306 (12) | 18 (11) | 288 (12) |
| Aspirin use, n (%) | 725 (27) | 62 (38) | 663 (27) |
Continuous variables are expressed as mean ± standard deviation.
Dichotomous variables are expressed as n (%).